A plant-produced H1N1 trimeric hemagglutinin protects mice from a lethal influenza virus challenge

References

• Gerhard W, Yewdell J, Frankel ME, Webster R. Antigenic structure of influenza virus haemagglutinin defined by hybridoma antibodies. Nature 1981; 290:713 - 7; http://dx.doi.org/10.1038/290713a0; PMID: 6163993
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention (CDC). Estimates of deaths associated with seasonal influenza --- United States, 1976-2007. MMWR Morb Mortal Wkly Rep 2010; 59:1057 - 62; PMID: 20798667
   PubMedGoogle Scholar
• Centers for Disease Control and Prevention (CDC). Swine-origin influenza A (H1N1) virus infections in a school - New York City, April 2009. MMWR Morb Mortal Wkly Rep 2009; 58:470 - 2; PMID: 19444151
   PubMedGoogle Scholar
• Domínguez-Cherit G, Lapinsky SE, Macias AE, Pinto R, Espinosa-Perez L, de la Torre A, et al. Critically Ill patients with 2009 influenza A(H1N1) in Mexico. JAMA 2009; 302:1880 - 7; http://dx.doi.org/10.1001/jama.2009.1536; PMID: 19822626
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. Updated estimates of 2009 H1N1 Influenza Cases, Hospitalizations and Deaths in the United States, April 2009 – April 10, 2010. May 14, 2010. http://www.cdc.gov/h1n1flu/estimates_2009_h1n1.htm (accessed 16 September 2012).
   Google Scholar
• Wilson IA, Cox NJ. Structural basis of immune recognition of influenza virus hemagglutinin. Annu Rev Immunol 1990; 8:737 - 71; http://dx.doi.org/10.1146/annurev.iy.08.040190.003513; PMID: 2188678
   PubMed Web of Science ®Google Scholar
• Han T, Marasco WA. Structural basis of influenza virus neutralization. Ann N Y Acad Sci 2011; 1217:178 - 90; http://dx.doi.org/10.1111/j.1749-6632.2010.05829.x; PMID: 21251008
   PubMed Web of Science ®Google Scholar
• Treanor JJ, Schiff GM, Couch RB, Cate TR, Brady RC, Hay CM, et al. Dose-related safety and immunogenicity of a trivalent baculovirus-expressed influenza-virus hemagglutinin vaccine in elderly adults. J Infect Dis 2006; 193:1223 - 8; http://dx.doi.org/10.1086/503050; PMID: 16586358
   PubMed Web of Science ®Google Scholar
• Cox MM, Patriarca PA, Treanor J. FluBlok, a recombinant hemagglutinin influenza vaccine. Influenza Other Respi Viruses 2008; 2:211 - 9; http://dx.doi.org/10.1111/j.1750-2659.2008.00053.x; PMID: 19453397
   PubMed Web of Science ®Google Scholar
• Keitel WA, Treanor JJ, El Sahly HM, Gilbert A, Meyer AL, Patriarca PA, et al. Comparative immunogenicity of recombinant influenza hemagglutinin (rHA) and trivalent inactivated vaccine (TIV) among persons > or =65 years old. Vaccine 2009; 28:379 - 85; http://dx.doi.org/10.1016/j.vaccine.2009.10.037; PMID: 19879222
   PubMed Web of Science ®Google Scholar
• Chichester JA, Yusibov V. Plants as alternative systems for production of vaccines. Hum Vaccin 2007; 3:146 - 8; http://dx.doi.org/10.4161/hv.3.4.4148; PMID: 17643065
   PubMed Web of Science ®Google Scholar
• Mett V, Farrance CE, Green BJ, Yusibov V. Plants as biofactories. Biologicals 2008; 36:354 - 8; http://dx.doi.org/10.1016/j.biologicals.2008.09.001; PMID: 18938088
   PubMed Web of Science ®Google Scholar
• Rybicki EP. Plant-made vaccines for humans and animals. Plant Biotechnol J 2010; 8:620 - 37; http://dx.doi.org/10.1111/j.1467-7652.2010.00507.x; PMID: 20233333
   PubMed Web of Science ®Google Scholar
• Shoji Y, Chichester JA, Bi H, Musiychuk K, de la Rosa P, Goldschmidt L, et al. Plant-expressed HA as a seasonal influenza vaccine candidate. Vaccine 2008; 26:2930 - 4; http://dx.doi.org/10.1016/j.vaccine.2008.03.045; PMID: 18440103
   PubMed Web of Science ®Google Scholar
• Shoji Y, Bi H, Musiychuk K, Rhee A, Horsey A, Roy G, et al. Plant-derived hemagglutinin protects ferrets against challenge infection with the A/Indonesia/05/05 strain of avian influenza. Vaccine 2009; 27:1087 - 92; http://dx.doi.org/10.1016/j.vaccine.2008.11.108; PMID: 19100806
   PubMed Web of Science ®Google Scholar
• Shoji Y, Farrance CE, Bautista J, Bi H, Musiychuk K, Horsey A, et al. A plant-based system for rapid production of influenza vaccine antigens. Influenza Other Respi Viruses 2012; 6:204 - 10; http://dx.doi.org/10.1111/j.1750-2659.2011.00295.x; PMID: 21974811
   PubMed Web of Science ®Google Scholar
• Shoji Y, Chichester JA, Jones M, Manceva SD, Damon E, Mett V, et al. Plant-based rapid production of recombinant subunit hemagglutinin vaccines targeting H1N1 and H5N1 influenza. Hum Vaccin 2011; 7:Suppl 41 - 50; http://dx.doi.org/10.4161/hv.7.0.14561; PMID: 21266846
   PubMed Web of Science ®Google Scholar
• Fraunhofer USA Center for Molecular Biotechnology. Fraunhofer USA CMB Confirms Interim Results for Its Plant-Produced H1N1 Influenza Vaccine. March 21, 2012. http://www.businesswire.com/news/home/20120321005221/en/Fraunhofer-USA-CMB-Confirms-Interim-Results-Plant-Produced (accessed 15 October 2012).
   Google Scholar
• Medicago Inc. Medicago reports positive U.S. clinical trial results for its H1N1 / seasonal influenza vaccine. June 8, 2011. http://www.medicago.com/English/news/News-Releases/News-ReleaseDetails/2011/Medicago-reports-positive-US-clinical-trial-results-for-its-H1N1–seasonal-influenza-vaccine1125593/default.aspx (accessed 15 October 2012).
   Google Scholar
• Landry N, Ward BJ, Trépanier S, Montomoli E, Dargis M, Lapini G, et al. Preclinical and clinical development of plant-made virus-like particle vaccine against avian H5N1 influenza. PLoS One 2010; 5:e15559; http://dx.doi.org/10.1371/journal.pone.0015559; PMID: 21203523
   PubMed Web of Science ®Google Scholar
• Medicago Inc. Medicago reports positive Phase II final results for its avian flu pandemic vaccine. June 30, 2011. http://www.medicago.com/English/news/News-Releases/News-ReleaseDetails/2011/Medicago-reports-positive-Phase-II-final-results-for-its-avian-flu-pandemic-vaccine1125833/default.aspx (accessed 15 October 2012).
   Google Scholar
• Wei CJ, Xu L, Kong WP, Shi W, Canis K, Stevens J, et al. Comparative efficacy of neutralizing antibodies elicited by recombinant hemagglutinin proteins from avian H5N1 influenza virus. J Virol 2008; 82:6200 - 8; http://dx.doi.org/10.1128/JVI.00187-08; PMID: 18417563
   PubMed Web of Science ®Google Scholar
• Vanlandschoot P, Beirnaert E, Neirynck S, Saelens X, Jou WM, Fiers W. Molecular and immunological characterization of soluble aggregated A/Victoria/3/75 (H3N2) influenza haemagglutinin expressed in insect cells. Arch Virol 1996; 141:1715 - 26; http://dx.doi.org/10.1007/BF01718294; PMID: 8893793
   PubMed Web of Science ®Google Scholar
• D’Aoust MA, Lavoie PO, Couture MM, Trépanier S, Guay JM, Dargis M, et al. Influenza virus-like particles produced by transient expression in Nicotiana benthamiana induce a protective immune response against a lethal viral challenge in mice. Plant Biotechnol J 2008; 6:930 - 40; http://dx.doi.org/10.1111/j.1467-7652.2008.00384.x; PMID: 19076615
   PubMed Web of Science ®Google Scholar
• D’Aoust MA, Couture MM, Charland N, Trépanier S, Landry N, Ors F, et al. The production of hemagglutinin-based virus-like particles in plants: a rapid, efficient and safe response to pandemic influenza. Plant Biotechnol J 2010; 8:607 - 19; http://dx.doi.org/10.1111/j.1467-7652.2009.00496.x; PMID: 20199612
   PubMed Web of Science ®Google Scholar
• Khurana S, Wu J, Verma N, Verma S, Raghunandan R, Manischewitz J, et al. H5N1 virus-like particle vaccine elicits cross-reactive neutralizing antibodies that preferentially bind to the oligomeric form of influenza virus hemagglutinin in humans. J Virol 2011; 85:10945 - 54; http://dx.doi.org/10.1128/JVI.05406-11; PMID: 21865396
   PubMed Web of Science ®Google Scholar
• Cornelissen LA, de Vries RP, de Boer-Luijtze EA, Rigter A, Rottier PJ, de Haan CA. A single immunization with soluble recombinant trimeric hemagglutinin protects chickens against highly pathogenic avian influenza virus H5N1. PLoS One 2010; 5:e10645; http://dx.doi.org/10.1371/journal.pone.0010645; PMID: 20498717
   PubMed Web of Science ®Google Scholar
• Lin SC, Huang MH, Tsou PC, Huang LM, Chong P, Wu SC. Recombinant trimeric HA protein immunogenicity of H5N1 avian influenza viruses and their combined use with inactivated or adenovirus vaccines. PLoS One 2011; 6:e20052; http://dx.doi.org/10.1371/journal.pone.0020052; PMID: 21655326
   PubMedGoogle Scholar
• Weldon WC, Wang BZ, Martin MP, Koutsonanos DG, Skountzou I, Compans RW. Enhanced immunogenicity of stabilized trimeric soluble influenza hemagglutinin. PLoS One 2010; 5:pii:e12466; http://dx.doi.org/10.1371/journal.pone.0012466; PMID: 20824188
   PubMed Web of Science ®Google Scholar
• Kammerer RA, Kostrewa D, Progias P, Honnappa S, Avila D, Lustig A, et al. A conserved trimerization motif controls the topology of short coiled coils. Proc Natl Acad Sci U S A 2005; 102:13891 - 6; http://dx.doi.org/10.1073/pnas.0502390102; PMID: 16172398
   PubMed Web of Science ®Google Scholar
• Tao Y, Strelkov SV, Mesyanzhinov VV, Rossmann MG. Structure of bacteriophage T4 fibritin: a segmented coiled coil and the role of the C-terminal domain. Structure 1997; 5:789 - 98; http://dx.doi.org/10.1016/S0969-2126(97)00233-5; PMID: 9261070
   PubMed Web of Science ®Google Scholar
• Yang X, Lee J, Mahony EM, Kwong PD, Wyatt R, Sodroski J. Highly stable trimers formed by human immunodeficiency virus type 1 envelope glycoproteins fused with the trimeric motif of T4 bacteriophage fibritin. J Virol 2002; 76:4634 - 42; http://dx.doi.org/10.1128/JVI.76.9.4634-4642.2002; PMID: 11932429
   PubMed Web of Science ®Google Scholar
• Xu R, McBride R, Nycholat CM, Paulson JC, Wilson IA. Structural characterization of the hemagglutinin receptor specificity from the 2009 H1N1 influenza pandemic. J Virol 2012; 86:982 - 90; http://dx.doi.org/10.1128/JVI.06322-11; PMID: 22072785
   PubMed Web of Science ®Google Scholar
• Kapust RB, Tözsér J, Copeland TD, Waugh DS. The P1′ specificity of tobacco etch virus protease. Biochem Biophys Res Commun 2002; 294:949 - 55; http://dx.doi.org/10.1016/S0006-291X(02)00574-0; PMID: 12074568
   PubMed Web of Science ®Google Scholar
• Porath J. Immobilized metal ion affinity chromatography. Protein Expr Purif 1992; 3:263 - 81; http://dx.doi.org/10.1016/1046-5928(92)90001-D; PMID: 1422221
   PubMed Web of Science ®Google Scholar
• Herman EM, Tague BW, Hoffman LM, Kjemtrupp SE, Chrispeels MJ. Retention of phytohemagglutinin with carbohyterminal tetrapeptide KDEL in the nuclear envelope and the endoplasmic reticulum. Planta 1990; 182:302 - 12; http://dx.doi.org/10.1007/BF00197126
   Google Scholar
• Musiychuk K, Stephenson N, Bi H, Farrance CE, Orozovic G, Brodelius M, et al. A launch vector for the production of vaccine antigens in plants. Influenza Other Respi Viruses 2007; 1:19 - 25; http://dx.doi.org/10.1111/j.1750-2659.2006.00005.x; PMID: 19453476
   PubMed Web of Science ®Google Scholar
• Green BJ, Fujiki M, Mett V, Kaczmarczyk J, Shamloul M, Musiychuk K, et al. Transient protein expression in three Pisum sativum (green pea) varieties. Biotechnol J 2009; 4:230 - 7; http://dx.doi.org/10.1002/biot.200800256; PMID: 19156736
   PubMedGoogle Scholar
• Ilyushina NA, Khalenkov AM, Seiler JP, Forrest HL, Bovin NV, Marjuki H, et al. Adaptation of pandemic H1N1 influenza viruses in mice. J Virol 2010; 84:8607 - 16; http://dx.doi.org/10.1128/JVI.00159-10; PMID: 20592084
   PubMed Web of Science ®Google Scholar
• World Health Organization. WHO Manual on Animal Influenza Diagnosis and Surveillance. 2002.
   Google Scholar
• Noah DL, Hill H, Hines D, White EL, Wolff MC. Qualification of the hemagglutination inhibition assay in support of pandemic influenza vaccine licensure. Clin Vaccine Immunol 2009; 16:558 - 66; http://dx.doi.org/10.1128/CVI.00368-08; PMID: 19225073
   PubMed Web of Science ®Google Scholar